Open AccessMANAGEMENT OF GESTASIONAL DIABETES MELLITUS IN A BETA MAJOR THALASSEMIA PATIENT
Author(s) -
Troy Fonda,
Hermiovida
Publication year - 2021
Publication title -
current internal medicine research and practice surabaya journal
Language(s) - English
Resource type - Journals
ISSN - 2721-544X
DOI - 10.20473/cimrj.v2i2.26255
Subject(s) - gestational diabetes , medicine , thalassemia , pregnancy , diabetes mellitus , beta thalassemia , obstetrics , fetus , incidence (geometry) , pediatrics , gestation , endocrinology , biology , genetics , physics , optics
Gestational diabetes mellitus (GDM) is a hyperglycemic condition that is first discovered during pregnancy. GDM is a high-risk condition during pregnancy, for both mother and fetus. GDM affects about 1–14% of pregnancies. In the last 20 years, the incidence of gestational diabetes has been increasing. High iron load and disorders of iron metabolism have been associated with glucose metabolism. The beta thalassemias are a group of hereditary hemoglobinopathies. Treatment for beta thalassemias patients is transfusion, but intensive transfusion can aggravate iron overload in patients. In this study, a case of GDM in a pregnant woman with beta-thalassemia was reported.